![The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41575-020-00360-x/MediaObjects/41575_2020_360_Fig1_HTML.png)
The four epidemiological stages in the global evolution of inflammatory bowel disease | Nature Reviews Gastroenterology & Hepatology
![European Crohn´s and Colitis Organisation - ECCO - Report on the 16th IBD Intensive Advanced Course at ECCO'18 European Crohn´s and Colitis Organisation - ECCO - Report on the 16th IBD Intensive Advanced Course at ECCO'18](https://www.ecco-ibd.eu/images/6_Publication/6_2_ECCO_News/ECCO_News_Images/Issue1_2018/06_01_IBD%20Course_3.jpg)
European Crohn´s and Colitis Organisation - ECCO - Report on the 16th IBD Intensive Advanced Course at ECCO'18
![Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand? - Al Bakir - United European Gastroenterology Journal - Wiley Online Library Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand? - Al Bakir - United European Gastroenterology Journal - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/4d306d36-4433-49da-b093-551df5e5eeed/ueg212330-toc-0001-m.jpg)
Optimising inflammatory bowel disease surveillance and dysplasia management—Where do we stand? - Al Bakir - United European Gastroenterology Journal - Wiley Online Library
![European Crohn´s and Colitis Organisation - ECCO - Introduction to ECCO'20 IBD Intensive Advanced Course European Crohn´s and Colitis Organisation - ECCO - Introduction to ECCO'20 IBD Intensive Advanced Course](https://www.ecco-ibd.eu/images/1_About_ECCO/1_4_ECCO_Operational_Board/1_4_2_EduCom/Henit_Yanai_2018.jpg)
European Crohn´s and Colitis Organisation - ECCO - Introduction to ECCO'20 IBD Intensive Advanced Course
![Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine](https://www.cell.com/cms/attachment/443a474b-e613-4e8c-923e-a2f33214e3df/gr1_lrg.jpg)
Antibody signatures in inflammatory bowel disease: current developments and future applications: Trends in Molecular Medicine
![Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut](https://gut.bmj.com/content/gutjnl/70/6/1044/F1.large.jpg)
Adaptations to the current ECCO/ESPGHAN guidelines on the management of paediatric acute severe colitis in the context of the COVID-19 pandemic: a RAND appropriateness panel | Gut
![Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590257122000244-ga1.jpg)
Positioning biologics in the treatment of IBD: A practical guide – Which mechanism of action for whom? - ScienceDirect
![PDF) Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper PDF) Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper](https://i1.rgstatic.net/publication/339128416_Quality_of_Care_Standards_in_Inflammatory_Bowel_Diseases_a_European_Crohn's_and_Colitis_Organisation_ECCO_Position_Paper/links/5f345981a6fdcccc43c59a96/largepreview.png)
PDF) Quality of Care Standards in Inflammatory Bowel Diseases: a European Crohn's and Colitis Organisation [ECCO] Position Paper
![JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis](https://pub.mdpi-res.com/jcm/jcm-11-02302/article_deploy/html/images/jcm-11-02302-g001.png?1650457533)
JCM | Free Full-Text | An Update on Current Pharmacotherapeutic Options for the Treatment of Ulcerative Colitis
![JPM | Free Full-Text | Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non- Severe Disease JPM | Free Full-Text | Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non- Severe Disease](https://pub.mdpi-res.com/jpm/jpm-11-01130/article_deploy/html/images/jpm-11-01130-ag.png?1635832802)
JPM | Free Full-Text | Serum Interleukin (IL)-23 and IL-17 Profile in Inflammatory Bowel Disease (IBD) Patients Could Differentiate between Severe and Non- Severe Disease
![Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study Frontiers | Inflammatory Indexes for Assessing the Severity and Disease Progression of Ulcerative Colitis: A Single-Center Retrospective Study](https://www.frontiersin.org/files/Articles/851295/fpubh-10-851295-HTML-r1/image_m/fpubh-10-851295-g001.jpg)